Akribion Therapeutics
PrivateLast Round
Seed
Feb 4, 2025
Total Funding Raised
$8.32M
Company Overview
Akribion Therapeutics operates in Healthcare & Life Sciences and is based in Zwingenberg. Its latest recorded funding round was a Seed round in February 2025.
Akribion Therapeutics is a biotechnology company that develops a unique, RNA-guided, nuclease-based technology for programmable cell depletion.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Akribion Therapeutics Comparables
Compare Akribion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shape Therapeutics | 73% | |
| Tune Therapeutics | 71% | |
| Arbor Biotechnologies | 71% |
For institutional investors. Book with your work email.
Akribion Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Akribion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MP Beteiligungs-GmbH | Seed |
| BMH Beteiligungs-Managementgesellschaft Hessen | Seed |
| RV Invest | Seed |
| CARMA FUND | Seed |
| High-Tech Gründerfonds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 4, 2025
BioTech startup emerges from stealth mode.
- Feb 4, 2025
$8.64M raised in Seed round.
For institutional investors. Book with your work email.
Akribion Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Akribion Therapeutics's valuation, stock price, and market status.
Is Akribion Therapeutics a public or private company?
Akribion Therapeutics is a private company.
What is the current stock price of Akribion Therapeutics?
Akribion Therapeutics is a private company, so its shares have no public market price. Caplight tracks Akribion Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Akribion Therapeutics worth (valuation)?
Valuation information for Akribion Therapeutics is not publicly available.
Can I buy Akribion Therapeutics stock?
Akribion Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Akribion Therapeutics's last funding round?
Akribion Therapeutics's most recent funding round was Seed on February 4, 2025.
Who are the main investors in Akribion Therapeutics?
Key investors in Akribion Therapeutics include RV Invest, CARMA FUND.
Will Akribion Therapeutics IPO soon?
No public IPO plans have been announced for Akribion Therapeutics.
How can I track Akribion Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Akribion Therapeutics's shares on secondary markets.